UPDATE 9/23/15: Collect Records has officially separated from Martin Shkreli—read more here. Original story below.
Word has spread throughout the past few days of Martin Shkreli, head of Turing Pharmaceuticals, who has been thrust into headlines due to his decision to raise prices on a drug called Daraprim, from $13.50 a tablet to a whopping $750. Daraprim is a drug used to treat toxoplasmosis, something commonly associated with AIDS and cancer patients. While it is disturbing enough that someone would do this, Luke O’Neil at Bullett Media uncovered that Shkreli is also an avid fan of emo and punk music, and was outed as an investor of Collect Records, the independent record label founded by Geoff Rickly of Thursday and managed by Norman Brannon of Texas Is The Reason. Clearly, Shkreli’s pursuit of profits flies in the face of much of what punk rock’s foundation was built upon.
Dominic Palermo [pictured], frontman of Philadelphia shoegaze act Nothing, took to Facebook earlier today to share his thoughts on the situation. The reason Palermo weighed in is because Nothing had recently signed to Collect Records (information which was not yet public before this story broke). In his post, Palermo says he was told by Rickly that the label was being funded by “an old Thursday fan that wanted to give back to music and the arts” and that the band never met Shkreli. He goes on to say that Rickly had no idea of Shkreli’s business decisions at Turing Pharmaceuticals, describing the investor as “a soulless man” and a “monster” and describing Rickly as “a great guy.” You can find the full Facebook post below.
As of press time, neither Rickly, Brannon nor Collect as an entity has publicly responded to the news of Shkreli’s actions, however Brannon has removed the Collect Records information page from his personal website (a page that as of September 19 was still there).